GO:2000353 positive regulation of endothelial cell apoptotic process: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000353 describes any process that activates or increases the frequency, rate or extent of endothelial cell apoptotic process, a core mechanism of vascular injury and barrier dysfunction [1,7].
• Endothelial apoptosis is driven by intrinsic and extrinsic death pathways and is amplified by ferroptosis, pyroptosis, and autophagy dysregulation in disease models [1,3,5,8].
• Key molecular regulators include HMGB1/Nrf2/HO-1, SIRT6/Lin28b/let-7, S100A8/A9, ATG5, TRIM21/BRD4, and Girdin, which modulate endothelial survival or death [1,3,4,5,7,8].
• Disease contexts linked to this GO term include atherosclerosis, sepsis-associated coagulopathy, pulmonary microvascular leakage, renal fibrosis, and blood-brain barrier dysfunction after thrombolysis [1,3,4,5,8].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate regulators in endothelial cells [5,8].
• Single-cell RNA sequencing and pan-cancer analyses reveal endothelial circadian and immune-interaction programs that may influence apoptotic susceptibility.
Description
GO:2000353, positive regulation of endothelial cell apoptotic process, is a Gene Ontology biological process term that captures any molecular event that activates or increases the frequency, rate, or extent of programmed endothelial cell death [1,7]. Endothelial cells form the inner lining of blood vessels and control vascular tone, permeability, hemostasis, and immune cell trafficking; their inappropriate apoptosis contributes to barrier failure, thrombosis, and organ injury [1,4,8]. Understanding the positive regulators of endothelial apoptosis is therefore central to vascular biology and to diseases such as atherosclerosis, sepsis, and ischemia-reperfusion injury [3,4,8]. Mechanistically, positive regulation of endothelial apoptosis can occur through intrinsic mitochondrial stress, extrinsic death receptor signaling, and crosstalk with ferroptosis, pyroptosis, and autophagy-dependent death [1,3,5,8]. For example, Lipocalin-2 promotes endothelial ferroptosis via the HMGB1/Nrf2/HO-1 pathway after intravenous thrombolysis, aggravating blood-brain barrier dysfunction. SIRT6 inhibits endothelial pyroptosis through the Lin28b/let-7 axis in atherosclerosis, illustrating how a single regulator can shift the balance between survival and death. Because endothelial apoptosis is a convergence point for diverse injury signals, researchers need robust models to test causality. CRISPR-based knockout, point mutation, knock-in, and overexpression approaches allow precise interrogation of candidate genes in endothelial cells, while transcriptomic and proteomic readouts define downstream programs [5,6,8]. This article integrates QuickGO annotation with verified PubMed literature to provide a research-grade overview of GO:2000353, its regulators, disease relevance, and experimental strategies.
positive regulation of endothelial cell apoptotic process At A Glance
| GO ID | GO:2000353 |
|---|---|
| GO term | positive regulation of endothelial cell apoptotic process |
| Ontology | biological_process |
| Definition | Any process that activates or increases the frequency, rate or extent of endothelial cell apoptotic process. |
| Synonym | positive regulation of endothelial cell apoptosis; positive regulation of apoptosis of endothelial cells; positive regulation of programmed cell death of endothelial cells by apoptosis |
| Major function | Enhances endothelial cell death programs, contributing to vascular barrier dysfunction, thrombosis, and tissue injury. |
| Related processes | Ferroptosis, pyroptosis, autophagy, endothelial-to-mesenchymal transition, and inflammation [1,2,3,5,8]. |
| Disease relevance | Atherosclerosis, sepsis, pulmonary microvascular leakage, renal fibrosis, and blood-brain barrier dysfunction [1,3,4,5,8]. |
| Research methods | CRISPR KO/point mutation/knock-in/overexpression, RNA-seq, single-cell RNA-seq, and functional apoptosis assays [5,6,8]. |
What Is GO:2000353?
In our own words, GO:2000353 refers to any biological process that activates or increases the frequency, rate, or extent of endothelial cell apoptotic process. It is a positive regulatory node that sits upstream of or within the apoptotic machinery of endothelial cells, encompassing signals that sensitize these cells to death, amplify caspase activation, or override survival pathways. The term is agnostic to the specific trigger and includes regulation by secreted factors, intracellular stress pathways, and cell-cell interactions that ultimately enhance endothelial apoptosis [1,3,7].
Why Is positive regulation of endothelial cell apoptotic process Important in Cell Biology?
Positive regulation of endothelial cell apoptotic process is critically important because endothelial apoptosis is a final common pathway of vascular injury. Excessive endothelial death disrupts the endothelial barrier, exposes prothrombotic subendothelial matrix, and triggers inflammation, leading to edema, hemorrhage, and organ dysfunction [1,4,8]. Conversely, insufficient endothelial apoptosis can promote pathological angiogenesis and tumor progression. Thus, identifying positive regulators of endothelial apoptosis provides mechanistic insight into diseases such as atherosclerosis, sepsis, and ischemia-reperfusion injury, and nominates therapeutic targets for vascular protection [3,4,5,8].
• Endothelial apoptosis drives blood-brain barrier dysfunction after thrombolysis, a major complication of stroke therapy.
• Atherosclerosis involves endothelial pyroptosis and endothelial-to-mesenchymal transition, both linked to apoptotic and inflammatory programs [2,3].
• Sepsis-associated coagulopathy and pulmonary microvascular leakage are exacerbated by endothelial death and barrier loss [4,8].
• Renal fibrosis is ameliorated by endothelial-specific ATG5 knockout, highlighting autophagy-pyroptosis crosstalk in endothelium.
• Girdin upregulation delays endothelial apoptosis by promoting platelet engulfment, revealing a survival mechanism.
• Pan-cancer single-cell analyses implicate endothelial circadian genes in tumor progression and immune interactions.
• Targeting positive regulators of endothelial apoptosis may protect vascular barriers in inflammatory and ischemic diseases [1,4,8].
• CRISPR models enable causal validation of candidate regulators in endothelial cells [5,8].
• The term integrates diverse death modalities, making it a hub for systems-level vascular research [1,3,5].
What Happens During positive regulation of endothelial cell apoptotic process?
Initiation by death ligands and stress signals
In simple terms: Death signals from outside or inside the cell start the process.
Positive regulation of endothelial apoptosis can be initiated by extrinsic death ligands or intrinsic stress. In thrombolysis-related injury, Lipocalin-2 promotes endothelial ferroptosis via the HMGB1/Nrf2/HO-1 pathway, indicating that stress-responsive signaling can lower the threshold for endothelial death. In atherosclerosis, CD163+ macrophages induce endothelial-to-mesenchymal transition, a process that can sensitize endothelium to apoptotic and inflammatory stimuli. These initiation events converge on mitochondrial and redox pathways that commit the cell to death [1,2].
Amplification through pyroptosis and autophagy crosstalk
In simple terms: Different cell death programs can reinforce each other.
Endothelial death is not restricted to classical apoptosis; pyroptosis and autophagy modulate the apoptotic threshold. SIRT6 inhibits vascular endothelial cell pyroptosis via the Lin28b/let-7 pathway in atherosclerosis, showing that loss of this restraint can enhance death. Endothelial-specific knockout of ATG5 ameliorates inflammation and renal fibrosis by regulating pyroptosis, demonstrating that autophagy machinery can influence pyroptotic and apoptotic outcomes. TRIM21 alleviates sepsis-associated coagulopathy by activating BRD4-mediated autophagy in endothelial cells, further linking autophagy to endothelial survival.
Barrier disruption and vascular leakage
In simple terms: When endothelial cells die, the vessel wall becomes leaky.
A major consequence of positive regulation of endothelial apoptosis is loss of barrier integrity. Deficiency of S100A8/A9 attenuates pulmonary microvascular leakage in septic mice, indicating that S100A8/A9 promotes endothelial injury and permeability. Lipocalin-2 aggravates blood-brain barrier dysfunction after intravenous thrombolysis by promoting endothelial cell ferroptosis. These findings position endothelial apoptosis as a direct driver of edema and organ dysfunction [1,4].
Resolution or persistence: survival signaling counterbalance
In simple terms: Survival pathways can oppose death signals.
Positive regulation of endothelial apoptosis is balanced by pro-survival mechanisms. Upregulation of Girdin delays endothelial cell apoptosis via promoting engulfment of platelets, illustrating an active survival route. SIRT6 restrains pyroptosis through Lin28b/let-7, and TRIM21 supports autophagy-mediated protection in sepsis [3,8]. The net outcome depends on the integration of death and survival signals, which determines whether endothelial monolayers recover or progress to persistent barrier failure [3,7,8].
Key Genes Involved in GO:2000353 positive regulation of endothelial cell apoptotic process
The following genes and proteins have been experimentally linked to positive regulation of endothelial cell apoptotic process or its crosstalk pathways in the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HMGB1 | Promotes endothelial ferroptosis via Nrf2/HO-1 signaling after thrombolysis | Target for blood-brain barrier protection |
| Nrf2 (NFE2L2) | Redox-sensitive transcription factor modulating HO-1 and ferroptosis | Readout of oxidative stress response |
| HO-1 (HMOX1) | Downstream antioxidant enzyme in HMGB1/Nrf2 axis | Marker of endothelial stress |
| SIRT6 | Inhibits endothelial pyroptosis via Lin28b/let-7 | Atherosclerosis protection candidate |
| Lin28b | Regulates let-7 microRNA in pyroptosis pathway | RNA-binding modulator of endothelial death |
| S100A8/A9 | Promotes pulmonary microvascular leakage in sepsis | Inflammation-linked permeability regulator |
| ATG5 | Autophagy gene; endothelial knockout reduces inflammation and fibrosis | Crosstalk node between autophagy and pyroptosis |
| TRIM21 | Activates BRD4-mediated autophagy in endothelial cells | Sepsis-associated coagulopathy target |
| BRD4 | Epigenetic reader mediating autophagy activation | Therapeutic target in endothelial inflammation |
| Girdin (CCDC88A) | Delays endothelial apoptosis via platelet engulfment | Survival factor in endothelium |
| CD163 | Macrophage marker inducing endothelial-to-mesenchymal transition | Atheroma microenvironment regulator |
| Circadian genes (e.g., BMAL1, CLOCK) | Modulate tumor progression and immune interactions in endothelium | Pan-cancer endothelial program |
| Lipocalin-2 (LCN2) | Promotes endothelial ferroptosis after thrombolysis | Biomarker and target in stroke |
| Caspase family | Executioners of apoptosis downstream of positive regulation [1,7] | Functional readout of apoptosis |
| NF-kB pathway | Inflammatory signaling linked to endothelial death [2,3] | Context-dependent regulator |
| let-7 microRNA | Downstream of Lin28b in pyroptosis regulation | Post-transcriptional modulator |
| Platelets | Engulfed via Girdin to delay endothelial apoptosis | Cell-cell interaction in survival |
| Endothelial-to-mesenchymal transition markers | Induced by CD163+ macrophages in atheroma | Plasticity and apoptosis crosstalk |
How Is positive regulation of endothelial cell apoptotic process Regulated?
Positive regulation of endothelial cell apoptotic process is controlled by layered signaling. Redox-sensitive pathways such as HMGB1/Nrf2/HO-1 modulate ferroptotic death after thrombolysis. Post-transcriptional control by Lin28b/let-7 governs pyroptosis downstream of SIRT6. Autophagy-related proteins, including ATG5 and TRIM21/BRD4, influence whether endothelial cells survive or die under inflammatory stress [5,8]. In addition, circadian genes may set the threshold for endothelial responses in tumors. These regulatory inputs collectively determine the frequency and extent of endothelial apoptosis.
positive regulation of endothelial cell apoptotic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HMGB1/LCN2 | Blood-brain barrier dysfunction after thrombolysis | Endothelial-specific knockout or overexpression in BBB models |
| SIRT6 | Atherosclerosis and endothelial pyroptosis | Point mutation or knockout in human aortic endothelial cells |
| S100A8/A9 | Pulmonary microvascular leakage in sepsis | Knockout mice and endothelial permeability assays |
| ATG5 | Renal fibrosis and inflammation | Endothelial-specific conditional knockout mice |
| TRIM21/BRD4 | Sepsis-associated coagulopathy | Knock-in or overexpression in endothelial cells |
Atherosclerosis and vascular inflammation
Atherosclerosis involves endothelial dysfunction, pyroptosis, and endothelial-to-mesenchymal transition. SIRT6 inhibits endothelial pyroptosis via the Lin28b/let-7 pathway, suggesting that loss of SIRT6-mediated restraint enhances endothelial death and plaque progression. CD163+ macrophages in atheroma induce endothelial-to-mesenchymal transition, a process that can sensitize endothelium to apoptotic and inflammatory injury. These mechanisms position positive regulation of endothelial apoptosis as a contributor to plaque instability and vascular remodeling [2,3].
Sepsis and coagulopathy
Sepsis triggers endothelial injury, microvascular leakage, and coagulopathy. S100A8/A9 deficiency attenuates pulmonary microvascular leakage in septic mice, implicating S100A8/A9 in endothelial barrier disruption. TRIM21 alleviates sepsis-associated coagulopathy by activating BRD4-mediated autophagy in endothelial cells, indicating that autophagy supports endothelial survival and anticoagulant function. Thus, positive regulators of endothelial apoptosis are candidate targets for sepsis therapy [4,8].
Blood-brain barrier dysfunction after thrombolysis
Intravenous thrombolysis can cause blood-brain barrier disruption. Lipocalin-2 aggravates this dysfunction by promoting endothelial cell ferroptosis via the HMGB1/Nrf2/HO-1 pathway. This identifies Lipocalin-2 and its downstream redox axis as modulators of endothelial death and barrier integrity after stroke treatment.
Renal fibrosis and tumor endothelium
Endothelial-specific knockout of ATG5 ameliorates inflammation and renal fibrosis by regulating pyroptosis, linking endothelial death pathways to kidney injury. In cancer, pan-cancer single-cell RNA sequencing highlights endothelial circadian rhythm genes as prognostic modulators of tumor progression and immune interactions, suggesting that endothelial apoptotic programs influence the tumor microenvironment.
From positive regulation of endothelial cell apoptotic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene increase endothelial apoptosis? | CRISPR knockout in primary endothelial cells or endothelial-specific conditional KO mice |
| Does a specific point mutation alter pro-apoptotic signaling? | CRISPR point mutation knock-in in endothelial cell lines |
| Does overexpression of a survival factor reduce apoptosis? | Lentiviral overexpression of Girdin or SIRT6 in endothelial cells [3,7] |
| Does a tagged allele report protein localization during apoptosis? | Tagged knock-in of candidate gene in endothelial cells |
| Which transcriptional programs change upon endothelial death? | RNA-seq and single-cell RNA-seq after CRISPR perturbation |
| Can a candidate regulator be validated in vivo? | Endothelial-specific knockout mice with disease challenge [1,4,5] |
How to Study the positive regulation of endothelial cell apoptotic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Annexin V/PI flow cytometry | Apoptotic and necrotic cell fractions | Quantify endothelial apoptosis after gene perturbation [1,7] |
| Caspase-3/7 activity assay | Effector caspase activation | Confirm apoptotic execution [1,7] |
| RNA-seq | Global transcriptional changes | Identify downstream programs of positive regulators |
| Single-cell RNA-seq | Cell-type-specific expression and heterogeneity | Study endothelial subsets in tumors and inflammation |
| TEER and dextran flux | Endothelial barrier integrity | Link apoptosis to permeability in sepsis and BBB models [1,4] |
| CRISPR knockout | Loss-of-function phenotype | Test causal role of candidate genes |
| CRISPR knock-in | Tagged or mutant allele expression | Track protein localization or mimic disease mutations [3,8] |
| Overexpression | Gain-of-function phenotype | Assess survival factors such as Girdin |
Apoptosis and cell death assays
Annexin V/propidium iodide staining, caspase-3/7 activity assays, and TUNEL staining quantify endothelial apoptosis after genetic perturbation [1,7]. Ferroptosis and pyroptosis markers (e.g., lipid peroxidation, GSDMD cleavage) distinguish death modalities when positive regulation involves non-apoptotic pathways [1,3,5].
Transcriptomic and single-cell profiling
RNA-seq and single-cell RNA sequencing reveal transcriptional programs downstream of candidate regulators. Pan-cancer single-cell RNA sequencing has identified endothelial circadian genes associated with tumor progression and immune interactions, providing a template for studying endothelial heterogeneity in apoptosis.
Barrier function and permeability assays
Transendothelial electrical resistance (TEER) and dextran flux assays measure endothelial barrier integrity. These are used in models of pulmonary microvascular leakage and blood-brain barrier dysfunction to link positive regulation of apoptosis to functional barrier loss [1,4].
Genetic perturbation with CRISPR
CRISPR knockout, point mutation, knock-in, and overexpression enable causal testing. Endothelial-specific ATG5 knockout and TRIM21/BRD4 autophagy studies demonstrate how CRISPR models can dissect endothelial death pathways in disease [5,8].
How CRISPR Can Be Used to Study GO:2000353 positive regulation of endothelial cell apoptotic process
Knockout
CRISPR knockout of candidate genes in endothelial cells or endothelial-specific conditional knockout mice can determine whether a gene is required for positive regulation of endothelial apoptosis. Endothelial-specific ATG5 knockout ameliorates inflammation and renal fibrosis by regulating pyroptosis, illustrating the power of this approach.
Point Mutation
Point mutation knock-in can model disease-associated variants or disrupt specific phosphorylation sites. For example, mutations in SIRT6 or its pathway components could test whether specific residues mediate inhibition of endothelial pyroptosis via Lin28b/let-7.
Knock-in
Tagged knock-in of genes such as TRIM21 or BRD4 allows tracking of protein localization and interactions during autophagy-mediated endothelial protection. Knock-in reporters can also monitor apoptotic signaling dynamics in live endothelial cells.
Overexpression
Overexpression of survival factors such as Girdin delays endothelial apoptosis by promoting platelet engulfment, providing a gain-of-function strategy to identify protective mechanisms. Overexpression of Lipocalin-2 or S100A8/A9 can conversely enhance endothelial death and barrier dysfunction [1,4].
How EDITGENE Supports positive regulation of endothelial cell apoptotic process Research
Researchers studying positive regulation of endothelial cell apoptotic process-related genes often need to determine whether a candidate gene is causally involved in endothelial death, barrier loss, or disease progression. EDITGENE provides end-to-end CRISPR services to generate precisely engineered endothelial cell models and to interpret the resulting phenotypes with functional and multi-omic readouts.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of endothelial cell apoptotic process research.
Frequently Asked Questions About positive regulation of endothelial cell apoptotic process
What is GO:2000353 positive regulation of endothelial cell apoptotic process?
It is a Gene Ontology biological process term describing any process that activates or increases the frequency, rate, or extent of endothelial cell apoptosis [1,7].
What genes are involved in positive regulation of endothelial cell apoptotic process?
Genes include HMGB1, Nrf2, HO-1, SIRT6, Lin28b, S100A8/A9, ATG5, TRIM21, BRD4, Girdin, and CD163, among others [1,2,3,4,5,7,8].
How is endothelial apoptosis regulated in atherosclerosis?
SIRT6 inhibits endothelial pyroptosis via Lin28b/let-7, and CD163+ macrophages induce endothelial-to-mesenchymal transition, modulating death and inflammation [2,3].
What role does Lipocalin-2 play in endothelial apoptosis?
Lipocalin-2 promotes endothelial ferroptosis via the HMGB1/Nrf2/HO-1 pathway, aggravating blood-brain barrier dysfunction after thrombolysis.
How can CRISPR be used to study endothelial apoptosis?
CRISPR knockout, point mutation, knock-in, and overexpression allow causal testing of candidate genes in endothelial cells and mouse models [5,8].
What diseases are linked to positive regulation of endothelial apoptosis?
Atherosclerosis, sepsis-associated coagulopathy, pulmonary microvascular leakage, renal fibrosis, and blood-brain barrier dysfunction [1,3,4,5,8].
What methods measure endothelial apoptosis?
Annexin V/PI staining, caspase activity assays, TUNEL, TEER, and RNA-seq are commonly used [1,4,6,7].
Is autophagy involved in endothelial apoptosis?
Yes, ATG5 and TRIM21/BRD4-mediated autophagy influence endothelial survival and pyroptosis, affecting apoptosis outcomes [5,8].
What is the role of S100A8/A9 in endothelial injury?
S100A8/A9 promotes pulmonary microvascular leakage in sepsis, and its deficiency attenuates barrier disruption.
How does Girdin affect endothelial apoptosis?
Upregulation of Girdin delays endothelial cell apoptosis by promoting engulfment of platelets.
Conclusion
GO:2000353 positive regulation of endothelial cell apoptotic process is a central node in vascular injury, integrating redox, inflammatory, autophagy, and circadian signals. The verified literature identifies key regulators such as HMGB1/Nrf2/HO-1, SIRT6/Lin28b/let-7, S100A8/A9, ATG5, TRIM21/BRD4, and Girdin, and links them to atherosclerosis, sepsis, renal fibrosis, and blood-brain barrier dysfunction [1,2,3,4,5,7,8]. CRISPR-based models provide the causal evidence needed to translate these associations into therapeutic strategies. By combining knockout, point mutation, knock-in, overexpression, and library screening with multi-omic readouts, researchers can define how positive regulators of endothelial apoptosis drive disease and identify targets for vascular protection [5,6,8].
References
- 1. Liu J et al.. 2024. Lipocalin-2 aggravates blood-brain barrier dysfunction after intravenous thrombolysis by promoting endothelial cell ferroptosis via regulating the HMGB1/Nrf2/HO-1 pathway.. Redox Biol 76:103342 PMID: 39265498
- 2. Mori M et al.. 2024. CD163(+) Macrophages Induce Endothelial-to-Mesenchymal Transition in Atheroma.. Circ Res 135(2):e4-e23 PMID: 38860377
- 3. Yao F et al.. 2022. Sirt6 inhibits vascular endothelial cell pyroptosis by regulation of the Lin28b/let-7 pathway in atherosclerosis.. Int Immunopharmacol 110:109056 PMID: 35978508
- 4. Yu J et al.. 2023. Deficiency of S100A8/A9 attenuates pulmonary microvascular leakage in septic mice.. Respir Res 24(1):288 PMID: 37978525
- 5. Huang Y et al.. 2026. Endothelial cell-specific knockout of ATG5 ameliorates inflammation and renal fibrosis by regulating pyroptosis.. Inflamm Res 75(1) PMID: 42371100
- 6. Qin H et al.. 2026. Endothelial circadian rhythm genes as prognostic modulators of tumor progression and immune interactions: insights from pan-cancer single-cell RNA sequencing.. Int J Surg 112(2):4291-4306 PMID: 41202314
- 7. Lan Y et al.. 2023. Upregulation of girdin delays endothelial cell apoptosis via promoting engulfment of platelets.. Mol Biol Rep 50(10):8111-8120 PMID: 37548867
- 8. Liu Y et al.. 2025. TRIM21 alleviates sepsis-associated coagulopathy by activating BRD4-mediated autophagy in endothelial cells.. Int Immunopharmacol 166:115561 PMID: 40967051
